326
Participants
Start Date
January 31, 2012
Primary Completion Date
March 31, 2018
Study Completion Date
December 31, 2024
RenalGuard Therapy
Induced Diuresis with matched replacement
Standard Therapy
Standard of care for patients at risk of CIN
NYU Medical Center, New York
Mount Sinai Medical Center, New York
Columbia University, New York
Montefiore Medical Center, New York
Stony Brook University Medical Center, Stony Brook
University of Pittsburgh, Pittsburgh
Guthrie Medical Center, Sayre
Washington Hospital Center, Washington D.C.
Johns Hopkins University, Baltimore
Rex Hospital, Raleigh
University of Florida, Jacksonville
Clearwater Cardiovascular, Clearwater
University of Alabama, Birmingham
North Mississippi Medical Center, Tupelo
Northern Michigan Hospital, Petoskey
Abbott Northwestern, Minneapolis
Advocate Good Samaritan, Downers Grove
Northwestern Memorial Hospital, Chicago
St. Joseph Medical Center, Saint Charles
Advocate Health, Naperville
St. John Research Institute, Bartlesville
Baylor Scott & White, Plano
Austin Heart Round Rock, Round Rock
Austin Heart Central, Austin
Torrance Medical Center, Torrance
St. Elizabeth's Hospital, Brighton
Cape Cod Healthcare, Hyannis
University of Massachusetts, Worcester
Rhode Island Hospital, Providence
The Miriam Hospital, Providence
Lead Sponsor
CardioRenal Systems, Inc.
INDUSTRY